Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,767 | 1,458 | 100.0% |
| Education | $5.26 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,507 | 132 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,475 | 208 | $0 (2022) |
| GlaxoSmithKline, LLC. | $1,138 | 90 | $0 (2024) |
| Novo Nordisk Inc | $1,032 | 128 | $0 (2023) |
| ABBVIE INC. | $935.45 | 59 | $0 (2024) |
| Amgen Inc. | $858.76 | 48 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $807.13 | 90 | $0 (2024) |
| PFIZER INC. | $762.05 | 147 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $706.72 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $679.98 | 66 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $857.90 | 47 | Paratek Pharmaceuticals, Inc. ($322.64) |
| 2023 | $1,021 | 58 | AbbVie Inc. ($423.29) |
| 2022 | $1,428 | 72 | Abbott Laboratories ($315.75) |
| 2021 | $1,694 | 109 | Esperion Therapeutics, Inc. ($212.95) |
| 2020 | $1,085 | 83 | AstraZeneca Pharmaceuticals LP ($227.43) |
| 2019 | $2,830 | 303 | Novartis Pharmaceuticals Corporation ($514.30) |
| 2018 | $3,230 | 381 | Novartis Pharmaceuticals Corporation ($400.38) |
| 2017 | $3,628 | 406 | Janssen Pharmaceuticals, Inc ($551.33) |
All Payment Transactions
1,459 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ANTIBIOTIC | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: ANTIBIOTIC | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $55.97 | General |
| Category: ANTIBIOTIC | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ANTIBIOTIC | ||||||
| 10/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: ANTIBIOTIC | ||||||
| 10/09/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: ANTIBIOTIC | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.17 | General |
| Category: Cardiovascular | ||||||
| 07/17/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: ANTIBIOTIC | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Respiratory | ||||||
| 07/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 931 | 1,848 | $167,638 | $73,285 |
| 2022 | 9 | 902 | 2,047 | $158,379 | $73,388 |
| 2021 | 10 | 1,021 | 2,241 | $170,675 | $80,413 |
| 2020 | 33 | 2,582 | 5,525 | $346,348 | $131,956 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 345 | 634 | $63,308 | $22,415 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 292 | $43,148 | $16,353 | 37.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 107 | 107 | $28,096 | $12,864 | 45.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 97 | 447 | $13,067 | $9,261 | 70.9% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 49 | 123 | $7,301 | $5,601 | 76.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 58 | 101 | $4,900 | $2,551 | 52.1% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 26 | 93 | $2,707 | $2,122 | 78.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $2,777 | $1,173 | 42.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 40 | $2,334 | $945.61 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 378 | 730 | $69,501 | $28,143 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 224 | 357 | $50,513 | $20,373 | 40.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 99 | 562 | $15,816 | $11,527 | 72.9% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 49 | 101 | $5,785 | $4,449 | 76.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 57 | 116 | $5,382 | $3,118 | 57.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $5,514 | $2,697 | 48.9% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 26 | 86 | $2,416 | $1,824 | 75.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 34 | 49 | $2,831 | $980.76 | 34.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 13 | 24 | $621.00 | $277.72 | 44.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 409 | 817 | $74,767 | $32,580 | 43.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 256 | 401 | $55,163 | $22,674 | 41.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 113 | 633 | $17,230 | $12,273 | 71.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 33 | 33 | $7,898 | $4,162 | 52.7% |
| 99487 | Complex chronic care management services, first 60 minutes clinical staff time per calendar month | Office | 2021 | 44 | 93 | $5,082 | $3,643 | 71.7% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 63 | 106 | $4,700 | $2,177 | 46.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 50 | 63 | $3,452 | $1,383 | 40.1% |
About Dr. Shawn Coffman, MD
Dr. Shawn Coffman, MD is a Internal Medicine healthcare provider based in Huntington, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720022643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shawn Coffman, MD has received a total of $15,773 in payments from pharmaceutical and medical device companies, with $857.90 received in 2024. These payments were reported across 1,459 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($15,767).
As a Medicare-enrolled provider, Coffman has provided services to 5,436 Medicare beneficiaries, totaling 11,661 services with total Medicare billing of $359,043. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Huntington, WV
- Active Since 06/15/2006
- Last Updated 04/24/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720022643
Products in Payments
- ENTRESTO (Drug) $1,477
- XARELTO (Drug) $1,051
- ELIQUIS (Drug) $914.56
- Ozempic (Drug) $625.73
- TRELEGY ELLIPTA (Drug) $589.69
- NUEDEXTA (Drug) $584.66
- JARDIANCE (Drug) $533.27
- VRAYLAR (Drug) $458.17
- XIFAXAN (Drug) $437.82
- Vascepa (Drug) $398.35
- NUZYRA (Drug) $341.03
- INVOKANA (Drug) $315.83
- LINZESS (Drug) $314.24
- FARXIGA (Drug) $310.86
- Repatha (Biological) $273.79
- FREESTYLE LIBRE (Device) $267.33
- LYRICA (Drug) $250.46
- NEXLETOL (Drug) $247.70
- Aimovig (Biological) $224.97
- ANORO (Drug) $223.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntington
Aamir Cheema, M.d, M.D
Internal Medicine — Payments: $207,509
Kofi Osei, Md, MD
Internal Medicine — Payments: $78,202
Wesam Frandah, Md, MD
Internal Medicine — Payments: $28,363
Murad Kheetan, Md, MD
Internal Medicine — Payments: $25,358
Rameez Sayyed, Md, MD
Internal Medicine — Payments: $24,444
David Patick, Md, MD
Internal Medicine — Payments: $23,768